We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STLA:NYSEStellantis N.V. Analysis

Data as of 2026-05-27 - not real-time

$7.81

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Stellantis trades at $7.81, just above its 20‑day and 50‑day SMAs of 7.51 but well below the 200‑day SMA of 9.24, indicating short‑term stability within a longer‑term downtrend. The RSI of 54.5 suggests neutral momentum, while the MACD histogram is positive (0.021) and the signal line is bullish, offering a modest technical upside. However, the stock faces extreme market sentiment (Extreme Greed index 91) amid a 30‑day volatility of 44.6% and a high beta of 1.53, underscoring pronounced price swings. Fundamentally, the company is distressed: a net loss of €2.3 bn, negative operating cash flow, and a max drawdown of -47.8% paired with a debt‑to‑equity ratio of 78.7. The forward PE of 4.42 and price‑to‑book of 0.35 make the stock appear cheap, yet profitability remains negative (trailing EPS –8.71) and dividend sustainability is doubtful despite a 10.58% yield.
The most material catalyst is a securities‑fraud lawsuit alleging that Stellantis overstated earnings guidance and EV market prospects, which could pressure the share price further and increase legal and regulatory risk. While the Microsoft AI partnership hints at future growth, the current financial strain, high payout ratio (84%), and ongoing litigation argue for caution. Investors should weigh the undervalued metrics against the severe earnings weakness and heightened risk environment before making a decision.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Pending securities‑fraud lawsuit
  • High short‑term volatility and beta
  • Price near technical resistance

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Undervalued valuation multiples
  • Potential upside from AI partnership and EV transition
  • Continued cash‑flow weakness and debt load

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Fundamental turnaround required to restore profitability
  • Sustainable dividend unlikely without earnings recovery
  • Exposure to global automotive cycles and regulatory changes

Key Metrics & Analysis

Financial Health

Revenue Growth6.50%
Profit Margin-13.87%
P/E Ratio4.4
ROE-30.15%
ROA-1.63%
Debt/Equity78.66
P/B Ratio0.3
Op. Cash Flow$-4521999872
Free Cash Flow$-5823000064

Technical Analysis

TrendNeutral
RSI54.5
Support$6.97
Resistance$7.99
MA 20$7.51
MA 50$7.51
MA 200$9.24
MACDBullish
VolumeStable
Fear & Greed Index91.07

Valuation

Target Price$9.14
Upside/Downside17.08%
GradeUndervalued
TypeBlend
Dividend Yield10.58%

Risk Assessment

Beta1.53
Volatility44.62%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.